Prevalence of malaria and its risk factors in Lake Tana and surrounding areas, northwest Ethiopia.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
04 Nov 2022
Historique:
received: 09 03 2022
accepted: 29 09 2022
entrez: 5 11 2022
pubmed: 6 11 2022
medline: 9 11 2022
Statut: epublish

Résumé

In Ethiopia, malaria is a major concern to the health, and socio-economic development of the country because of its occurrence at the peak agricultural activities. Factors such as environmental, human host, parasite, and vector determine malaria transmission. Therefore, the present study was conducted to determine the prevalence and associated factors of malaria among febrile patients who visited selected health centres. Institutional-based cross-sectional study was conducted between October 2020 to July 2021 in eight selected health centres located in Lake Tana and its surrounding areas. A simple random sampling technique was used to select febrile patients. Thick and thin blood films were prepared and processed according to the WHO guidelines. Socio-demographic and malaria risk factors were collected from study participants who could read and write using a self-administered questionnaire, whereas face-to-face interview was used to collect information from those participants who could not write and read. The strength of association between risk factors and malaria was assessed using univariate and multivariate logistic regression models. Of the total (531) febrile patients, 75.3% were malaria negative and 24.7% (overall prevalence) were malaria confirmed cases. Most of the infections were caused by Plasmodium falciparum (72.5%) followed by Plasmodium vivax (23.7%) and mixed-species (3.8%). The highest prevalence was recorded in Kidist Hana (51.5%) followed by Robit (34.8%), Gorgora (30.3%), and Wusha Tiris (25%) health centres. In terms of months, the highest prevalence (37.5%) was detected in October whereas the lowest (14%) was in March. Logistic regression analysis revealed that gender (p = 0.023), educational level (p = 0.025), study month (p = 0.036), presence of eave in the house (p = 0.002) and wall openings (p = 0.041), not using bed nets (p = 0.001), sleeping in the same house with cattle (p = 0.031) and the distance between mosquito-breeding site and living house (p = 0.020) were explanatory risk factors significantly associated with malaria among studied participants. In this study, we confirmed that the occurrence of malaria prevalence was high and continued against the Ethiopian malaria elimination plan of 2021-2025. Therefore, to meet the goals of this plan, the current prevention and control efforts should be stepped up even better in the coming years.

Sections du résumé

BACKGROUND BACKGROUND
In Ethiopia, malaria is a major concern to the health, and socio-economic development of the country because of its occurrence at the peak agricultural activities. Factors such as environmental, human host, parasite, and vector determine malaria transmission. Therefore, the present study was conducted to determine the prevalence and associated factors of malaria among febrile patients who visited selected health centres.
METHODS METHODS
Institutional-based cross-sectional study was conducted between October 2020 to July 2021 in eight selected health centres located in Lake Tana and its surrounding areas. A simple random sampling technique was used to select febrile patients. Thick and thin blood films were prepared and processed according to the WHO guidelines. Socio-demographic and malaria risk factors were collected from study participants who could read and write using a self-administered questionnaire, whereas face-to-face interview was used to collect information from those participants who could not write and read. The strength of association between risk factors and malaria was assessed using univariate and multivariate logistic regression models.
RESULTS RESULTS
Of the total (531) febrile patients, 75.3% were malaria negative and 24.7% (overall prevalence) were malaria confirmed cases. Most of the infections were caused by Plasmodium falciparum (72.5%) followed by Plasmodium vivax (23.7%) and mixed-species (3.8%). The highest prevalence was recorded in Kidist Hana (51.5%) followed by Robit (34.8%), Gorgora (30.3%), and Wusha Tiris (25%) health centres. In terms of months, the highest prevalence (37.5%) was detected in October whereas the lowest (14%) was in March. Logistic regression analysis revealed that gender (p = 0.023), educational level (p = 0.025), study month (p = 0.036), presence of eave in the house (p = 0.002) and wall openings (p = 0.041), not using bed nets (p = 0.001), sleeping in the same house with cattle (p = 0.031) and the distance between mosquito-breeding site and living house (p = 0.020) were explanatory risk factors significantly associated with malaria among studied participants.
CONCLUSIONS CONCLUSIONS
In this study, we confirmed that the occurrence of malaria prevalence was high and continued against the Ethiopian malaria elimination plan of 2021-2025. Therefore, to meet the goals of this plan, the current prevention and control efforts should be stepped up even better in the coming years.

Identifiants

pubmed: 36333723
doi: 10.1186/s12936-022-04310-7
pii: 10.1186/s12936-022-04310-7
pmc: PMC9636828
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

313

Informations de copyright

© 2022. The Author(s).

Références

Ethiop J Health Sci. 2019 Sep;29(5):613-622
pubmed: 31666783
Trop Dis Travel Med Vaccines. 2019 Jul 12;5:11
pubmed: 31338202
Malar J. 2015 Dec 15;14:501
pubmed: 26671012
Ethiop Med J. 2007 Apr;45(2):151-8
pubmed: 17642171
J Trop Med. 2021 Mar 04;2021:8863002
pubmed: 33747096
BMC Public Health. 2018 Aug 8;18(1):990
pubmed: 30089470
Malar J. 2011 Jun 24;10:173
pubmed: 21699741
Malar J. 2021 Aug 26;20(1):353
pubmed: 34446033
BMC Public Health. 2014 Apr 09;14:332
pubmed: 24712340
Arch Public Health. 2018 Dec 20;76:74
pubmed: 30598821
Ethiop J Health Sci. 2018 May;28(3):277-286
pubmed: 29983527
Trop Dis Travel Med Vaccines. 2018 Aug 10;4:8
pubmed: 30116548
Res Rep Trop Med. 2018 Jun 20;9:95-101
pubmed: 30050360
Parasit Vectors. 2011 Mar 31;4:46
pubmed: 21453465
Trop Med Infect Dis. 2017 Mar 01;2(1):
pubmed: 30270863
BMC Res Notes. 2017 Jul 4;10(1):239
pubmed: 28676117
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Ethiop Med J. 2014 Oct;52 Suppl 3:11
pubmed: 25845068
J Infect Public Health. 2009;2(4):171-6
pubmed: 20701879
Ethiop J Health Sci. 2018 Sep;28(5):539-546
pubmed: 30607068
Trop Med Int Health. 2011 Apr;16(4):486-91
pubmed: 21255205
Malar J. 2019 May 24;18(1):182
pubmed: 31126286
Ethiop Med J. 2004 Oct;42(4):237-46
pubmed: 16122115
Trop Med Int Health. 2008 Jan;13(1):108-22
pubmed: 18291009
Travel Med Infect Dis. 2007 Mar;5(2):135-7
pubmed: 17298922
Heliyon. 2020 Mar 20;6(3):e03616
pubmed: 32258471
BMC Public Health. 2017 Jul 17;18(1):25
pubmed: 28716009
Parasit Vectors. 2010 Feb 01;3(1):5
pubmed: 20205846
Jpn J Infect Dis. 2015;68(1):55-9
pubmed: 25420658
Parasit Vectors. 2012 Aug 14;5:173
pubmed: 22892288
Malar J. 2013 Sep 28;12:346
pubmed: 24073668
Acta Trop. 2016 Mar;155:63-70
pubmed: 26739654
J Parasitol Res. 2019 May 02;2019:8396091
pubmed: 31186950
Malar J. 2013 Sep 12;12:319
pubmed: 24028542
BMC Res Notes. 2019 Mar 29;12(1):190
pubmed: 30925942
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2375-80
pubmed: 14983017
Malar Res Treat. 2019 Dec 03;2019:7065064
pubmed: 32089818
Trends Ecol Evol. 2005 Jun;20(6):328-36
pubmed: 16701389
Malar J. 2019 Jul 22;18(1):246
pubmed: 31331340
Malar J. 2009 Jul 30;8:177
pubmed: 19642976
J Parasitol Res. 2020 Jan 29;2020:4204987
pubmed: 32411421
Lancet Infect Dis. 2004 Jun;4(6):327-36
pubmed: 15172341
Trans R Soc Trop Med Hyg. 1988;82(6):838-42
pubmed: 2908286
BMC Public Health. 2020 Jul 28;20(1):1175
pubmed: 32723306
J Infect Public Health. 2013 Feb;6(1):10-5
pubmed: 23290088
PLoS One. 2016 May 03;11(5):e0154277
pubmed: 27137913

Auteurs

Fasil Adugna (F)

Department of Biology, Bahir Dar University, 79, Bahir Dar, Ethiopia. fasiladugna@gmail.com.

Melaku Wale (M)

Department of Biology, Bahir Dar University, 79, Bahir Dar, Ethiopia.

Endalkachew Nibret (E)

Biotechnology Research Institute, Bahir Dar University, Bahir Dar, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH